Cargando…
Proteomics in Melanoma Biomarker Discovery: Great Potential, Many Obstacles
The present clinical staging of melanoma stratifies patients into heterogeneous groups, resulting in the application of aggressive therapies to large populations, diluting impact and increasing toxicity. To move to a new era of therapeutic decisions based on highly specific tumor profiling, the disc...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195774/ https://www.ncbi.nlm.nih.gov/pubmed/22084682 http://dx.doi.org/10.1155/2011/181890 |